Comparing day 3 vs day 5 assisted hatching in IVF
Part of Women’s health & pregnancy clinical trials.
This study compares two different days (day 3 vs day 5) to perform assisted hatching on embryos during an IVF cycle where genetic testing (PGT-A) is planned. The goal is to see which day helps embryos grow better and gives more accurate test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have genetic testing (PGT-A) on your embryos.
- You are using your own eggs and are between 20 and 45 years old, or you are using donor eggs and the donor is between 20 and 45.
- Your AMH level was between 1 and 10 ng/mL in the last 12 months.
- You have at least 5 small follicles visible on an ultrasound (done between day 2 and 5 of your cycle).
- You have not had 3 or more failed IVF cycles or 3 or more miscarriages in a row.
- You do not have PCOS, and your sperm sample comes from ejaculation (not surgery) with standard preparation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different timings for a lab procedure called assisted hatching (making a small opening in the embryo's outer shell) to see if one helps more embryos implant. You may be eligible if you're doing IVF with a frozen embryo transfer of a single screened embryo.
This trial compares transferring embryos at the cleavage stage (day 3) versus the blastocyst stage (day 5) for women who have few embryos during an IVF cycle. It may help determine which stage gives the best chance of pregnancy for people with limited embryos.
This study tests whether a special technique called assisted hatching (gently opening the outer shell of an embryo) can improve pregnancy success after a frozen embryo transfer in women aged 35 and older.
This study compares transferring embryos on day 2 versus day 3 after egg collection in women over 35 with low egg numbers or low AMH levels (a hormone that reflects egg reserve). The goal is to see which timing improves pregnancy success rates in this harder-to-treat group.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This study tests an upgraded method to screen embryos for genetic abnormalities before implantation during fertility treatment. It may help couples with age-related fertility concerns, repeated implantation failures, recurrent miscarriages, or male factor infertility achieve successful pregnancy.
Hear when a new Infertility; In Vitro Fertilization; Embryo Development trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.